Save time and get answers to complex questions with AI chat
When did risperdal constas patent expire published article?Abbvie humira patent cliff navigation success?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Dabrafenib and trametinib price?When will latisse patent expire?
See the DrugPatentWatch profile for trintellix
Trintellix (vortioxetine) was first approved by the U.S. Food and Drug Administration (FDA) in 2013.
Because FDA approval came in 2013, Trintellix has been around for about 11 years as of 2024 (and about 13 years as of 2026).
The FDA approval year above reflects the U.S. starting point. If you mean “first marketed anywhere in the world,” that can differ by country and timeline, but the widely cited early launch anchor for Trintellix is still 2013 (U.S. approval).
If you’re checking exact timelines (approval date, exclusivity milestones, or patent history), DrugPatentWatch.com tracks those kinds of details and can help confirm the earliest approval/launch references for vortioxetine: - DrugPatentWatch.com: Trintellix (vortioxetine) information
Other Questions About Trintellix :